CRISPR and Gene Editing Technologies Market Forecast
Comprehensive evaluation of the gene editing landscape including CRISPR/Cas9, TALENs and ZFNs, segmented by application and end-user.
Pages
312
CAGR
17.2%
Forecast
2026 - 2032
Coverage
Global TAM
Executive Abstract
The CRISPR market is witnessing explosive growth due to the rising prevalence of genetic disorders and an increasing focus on personalized medicine. This report provides a detailed 10-year forecast covering IP landscapes, regulatory hurdles across NA, EU, and APAC, and venture capital funding trends.
Table of Contents
- 1Executive Summary & Methodology
- 2Market Definition and Scope
- 3Market Dynamics: Drivers, Restraints & Opportunities
- 4Market Sizing & Forecast (2026 - 2032)
- 5Segment Analysis
- 6Regional Outlook
- 7Competitive Landscape & Company Profiles
- 8Strategic Recommendations
Key Players Analyzed
CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Thermo Fisher Scientific, and Precision BioSciences.
Accelerate Your Strategic Vision.
Whether you need a sample report, a custom intelligence dashboard, or direct M&A advisory, our domain experts are ready to assist.
Direct Contact
+1 (800) 445-6789
strategy@averonstrategy.com
Guaranteed 24h SLA
Expect a comprehensive scoping response from a specialized domain analyst within 24 hours.